Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma-A Single-Center Retrospective Cohort Study.
Fabian HuberElisabeth Zwickl-TraxlerMartin PecherstorferJosef SingerPublished in: Current oncology (Toronto, Ont.) (2021)
Future studies with larger patient cohorts are needed in order to elucidate the prognostic role of Ki-67 in patients with DLBCL treated with R-CHOP.